Andrew Huberman· PhD
thus far many (not all) companies are still selling it but with revised labeling.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
thus far many (not all) companies are still selling it but with revised labeling.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
A lot of companies have ceased selling it.
is nmn available over the counter it is more recently I can see it on the Internet